A Study to Determine Molecular Mechanisms in Breast Implant Associated-Anaplastic Large Cell Lymphoma


About this study

The purpose of this study is to utilize the systematic application of transcriptome-wide microarray to measure differential gene expression in banked breast implant associated-anaplastic large cell lymphoma (BIA-ALCL) tumor specimens and healthy control tissue.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Female patients.
  • Age ≥ 22 years old.
  • Undergoing tissue expander (TE) breast reconstruction following mastectomy for breast cancer inclusion.

Exclusion Criteria: 

  • Current breast pocket infection.



Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Brian Rinker, M.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer